The 9 H -xanthen-9-yl (Xan) and 2-methoxy-9 H -xanthen-9-yl (2-Moxan) groups can be introduced onto sulfhydryl functions by S -alkylation reactions involving the corresponding xanthydrols, plus trifluoroacetic acid (TFA) as catalyst. Conversely, these groups are removed rapidly by acid in the presence of appropriate silane or thiol scavengers. The 3-methoxy-9 H -xanthen-9-yl (3-Moxan) derivative was also studied, but abandoned for several reasons including challenging synthesis, excessive lability to acid, and insufficient stability in the presence of base. The N α -9-fluorenylmethyloxycarbonyl (Fmoc), S -Xan or 2-Moxan-protected cysteine derivatives were prepared and applied to the solid-phase syntheses of several model peptides. Selective removal of S -Xan and S -2-Moxan groups, while retaining tris(alkoxybenzyl)amide (PAL) anchoring, is best accomplished with TFA−CH 2 Cl 2 −Et 3 SiH (1:98.5:0.5), 25 °C, 2 h. Alternatively, oxidative deprotection of S -Xan or S -2-Moxan with iodine (10−20 equiv) or thallium(III) tris(trifluoroacetate) [Tl(tfa) 3 ] (1−3 equiv) to provide disulfides can be carried out on peptide substrates both in solution and while polymer-bound. Compared to established chemistries with the acid-labile and oxidizable S -triphenylmethyl (Trt) group, S -Xan and S -2-Moxan gave equal or superior results in terms of peptide purities (including no detectable tryptophan alkylation) and overall yields.
No takes yet. Share an insight, caveat, or question.
Han et al. (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: